Your browser doesn't support javascript.
loading
Pretreatment Serum MCP-1 Level Predicts Response to Risperidone in Schizophrenia.
Lin, Yezhe; Peng, Yanmin; Zhu, Cuizhen; Su, Yousong; Shi, Yuan; Lin, Zhiguang; Chen, Jinghong; Cui, Donghong.
Affiliation
  • Lin Y; Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Peng Y; Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China.
  • Zhu C; Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Su Y; Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China.
  • Shi Y; Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Lin Z; Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China.
  • Chen J; Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Cui D; Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai Arch Psychiatry ; 29(5): 287-294, 2017 Oct 25.
Article in En | MEDLINE | ID: mdl-29276352
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Shanghai Arch Psychiatry Year: 2017 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Shanghai Arch Psychiatry Year: 2017 Document type: Article Affiliation country: China Country of publication: China